Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: Implications for proximal colon cancer

American Journal of Gastroenterology

Volumn 107, Issue 8, 2012, Pages 1213-1219

  Burnett Hartman, Andrea N ^a,b   Newcomb, Polly A ^a,b   Phipps, Amanda I ^a,b   Passarelli, Michael N ^a,b   Grady, William M ^a,c   Upton, Melissa P ^c   Zhu, Lee Ching ^d   Potter, John D ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Group Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASCENDING COLON; CANCER PREVENTION; CASE CONTROL STUDY; COLON CANCER; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; DESCENDING COLON; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM ADENOMA; RISK; STRUCTURED QUESTIONNAIRE;

ADENOMA; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84864619936     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.167     Document Type: Article

References (55)

1. Hewitson P, Glasziou P, Watson E et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103: 1541-9. (Pubitemid 351813919)
2. Atkin W, Rogers P, Cardwell C et al. Wide variation in adenoma detection rates at screening fl exible sigmoidoscopy. Gastroenterology 2004; 126: 1247-56. (Pubitemid 38552789)
3. Brenner H. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 2001; 85: 972-6. (Pubitemid 33015999)
4. Baxter NN, Goldwasser MA, Paszat LF et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009; 150: 1-8.
5. Singh H, Nugent Z, Mahmud SM et al. Predictors of colorectal cancer aft er negative colonoscopy: a population-based study. Am J Gastroenterol 2010; 105: 663-73; quiz 674.
6. Newcomb PA, Norfl eet RG, Storer BE et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-5.
7. Selby JV. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. see comments. New Engl J Med 1992; 326: 653-7.
8. Atkin WS, Cuzick J, Northover JM et al. Prevention of colorectal cancer by once-only sigmoidoscopy. see comments. Lancet 1993; 341: 736-40. (Pubitemid 23085190)
9. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only fl exible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624-33.
10. Brenner H, Hoff meister M, Arndt V et al. Protection from right-and left-sided colorectal neoplasms aft er colonoscopy: population-based study. J Natl Cancer Inst 2010; 102: 89-95.
11. Singh G, Gerson LB, Wang H. Screening colonoscopy, colorectal cancer and gender: an unfair deal for the fair sex? Gastrointest Endosc 2007; 65: AB100.
12. Baxter NN, Warren J, Barrett MJ et al. The Association Between Colonoscopy and Colorectal Cancer Mortality in a U.S. Cohort According to Site of Cancer and Colonoscopist Speciality. Digestive Disease Week: Chicago, IL, 2011.
13. Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am 2002; 12: 1-9, v. (Pubitemid 34072776)
14. Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Aff airs Cooperative Study Group 380. erratum appears in N Engl J Med 2000 Oct 19;343(16):1204. N Engl J Med 2000; 343: 162-8.
15. Jass Jr. Molecular heterogeneity of colorectal cancer: implications for cancer control. Surg Oncol 2007; 16 (Suppl 1): S7-9.
16. Inadomi J. Editorial: Interval cancers aft er colonoscopy: the importance of training. Am J Gastroenterol 2010; 105: 2597-8.
17. Neugut AI, Lebwohl B. Colonoscopy vs. sigmoidoscopy screening: getting it right. JAMA 2010; 304: 461-2.
18. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-70. (Pubitemid 26358996)
19. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
20. Brenner H, Chang-Claude J, Seiler CM et al. Case-control study supports extension of surveillance interval aft er colonoscopic polypectomy to at least 5 yr. Am J Gastroenterol 2007; 102: 1739-44. (Pubitemid 47206678)
21. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-81. (Pubitemid 24015040)
22. Lieberman DA, Weiss DG, Harford WV et al. Five-year colon surveillance aft er screening colonoscopy. Gastroenterology 2007; 133: 1077-85. (Pubitemid 47494453)
23. Jass Jr. Classifi cation of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-30. (Pubitemid 44953403)
24. Lu FI, van Niekerk de W, Owen D et al. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol 2010; 34: 927-34.
25. Vaughn CP, Wilson AR, Samowitz WS. Quantitative evaluation of CpG island methylation in hyperplastic polyps. Mod Pathol 2010; 23: 151-6.
26. Huang CS, Farraye FA, Yang S et al. The clinical signifi cance of serrated polyps. Am J Gastroenterol 2011; 106: 229-40; quiz 241.
27. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011; 42: 1-10.
28. Torlakovic E, Skovlund E, Snover DC et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003; 27: 65-81. (Pubitemid 36014900)
29. O' Brien MJ, Yang S, Clebanoff JL et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 2004; 28: 423-34. (Pubitemid 38436515)
30. O' Brien MJ, Yang S, Mack C et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006; 30: 1491-501. (Pubitemid 44808785)
31. Spring KJ, Zhao ZZ, Karamatic R et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006; 131: 1400-7. (Pubitemid 44708940)
32. Barault L, Charon-Barra C, Jooste V et al. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 2008; 68: 8541-6.
33. Nosho K, Irahara N, Shima K et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One 2008; 3: e3698.
34. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-81. (Pubitemid 24015040)
35. Mannath J, Subramanian V, Singh R et al. Polyp recurrence aft er endoscopic mucosal resection of sessile and fl at colonic adenomas. Dig Dis Sci 2011; 56: 2389-95.
36. Kahi CJ, Hewett DG, Norton DL et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011; 9: 42-6.
37. Hetzel JT, Huang CS, Coukos JA et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol 2010; 105: 2656-64.
38. Chia VM, Newcomb PA, Lampe JW et al. Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2007; 16: 2697-703. (Pubitemid 351196326)
39. Burnett-Hartman AN, Newcomb PA, Mandelson MT et al. No Evidence for Human Papillomavirus in the Etiology of Colorectal Polyps. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011.
40. Burnett-Hartman AN, Newcomb PA, Mandelson MT et al. Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms. Nutr Cancer 2011; 63: 583-92.
41. Wernli KJ, Newcomb PA, Wang Y et al. Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res 2010; 20: 305-9.
42. Raghunathan TE, Lepkowski JV, Solenberger P. A Multivariate technique for multiply imputing missing values using a sequence of regression models . Surv Method 2001; 21: 85-95.
43. Arain MA, Sawhney M, Sheikh S et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010; 105: 1189-95.
44. Sawhney MS, Farrar WD, Gudiseva S et al. Microsatellite instability in interval colon cancers. Gastroenterology 2006; 131: 1700-5. (Pubitemid 44958526)
45. Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362: 1795-803.
46. Rabeneck L, Paszat LF, Saskin R. Endoscopist specialty is associated with incident colorectal cancer aft er a negative colonoscopy. Clin Gastroenterol Hepatol 2010; 8: 275-9.
47. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95. (Pubitemid 351615355)
48. Doria-Rose VP, Levin TR, Selby JV et al. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 2004; 127: 714-22. (Pubitemid 39208404)
49. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer aft er excision of rectosigmoid adenomas. N Engl J Med 1992; 326: 658-62.
50. Rabeneck L, Lewis JD, Paszat LF et al. Risk of proximal and distal colorectal cancer following fl exible sigmoidoscopy: a population-based cohort study. Am J Gastroenterol 2008; 103: 2075-82.
51. Collett JA, Platell C, Fletcher DR et al. Distal colonic neoplasms predict proximal neoplasia in average-risk, asymptomatic subjects. J Gastroenterol Hepatol 1999; 14: 67-71. (Pubitemid 29087320)
52. Pinsky PF, Schoen RE, Weissfeld JL et al. Predictors of advanced proximal neoplasia in persons with abnormal screening fl exible sigmoidoscopy. Clin Gastroenterol and Hepatol 2003; 1: 103-10. (Pubitemid 37248081)
53. Imperiale TF, Wagner DR, Lin CY et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal fi ndings. N Engl J Med 2000; 343: 169-74. (Pubitemid 30489213)
54. Schenck AP, Klabunde CN, Davis WW. Racial diff erences in colorectal cancer test use by medicare consumers. Am J Prev Med 2006; 30: 320-6. (Pubitemid 43357921)
55. Hall MJ, Ruth K, Giri VN. Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program. Cancer 2012; 118: 478-84.